(Q51748897)

English

The dose-dependent tumor targeting of antibody-IFNγ fusion proteins reveals an unexpected receptor-trapping mechanism in vivo.

scientific article published on 24 March 2014

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24795141

retrieved

11 April 2018

reference URL

http://europepmc.org/abstract/MED/24795141

title

The dose-dependent tumor targeting of antibody-IFNγ fusion proteins reveals an unexpected receptor-trapping mechanism in vivo. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24795141

retrieved

11 April 2018

reference URL

http://europepmc.org/abstract/MED/24795141

author

Dario Neri

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24795141

retrieved

11 April 2018

reference URL

http://europepmc.org/abstract/MED/24795141

author name string

Teresa Hemmerle

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24795141

retrieved

11 April 2018

reference URL

http://europepmc.org/abstract/MED/24795141

publication date

24 March 2014

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24795141

retrieved

11 April 2018

reference URL

http://europepmc.org/abstract/MED/24795141

published in

Cancer Immunology Research

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24795141

retrieved

11 April 2018

reference URL

http://europepmc.org/abstract/MED/24795141

volume

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24795141

retrieved

11 April 2018

reference URL

http://europepmc.org/abstract/MED/24795141

issue

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24795141

retrieved

11 April 2018

reference URL

http://europepmc.org/abstract/MED/24795141

page(s)

559-567

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24795141

retrieved

11 April 2018

reference URL

http://europepmc.org/abstract/MED/24795141

Identifiers

DOI

10.1158/2326-6066.CIR-13-0182

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24795141

retrieved

11 April 2018

reference URL

http://europepmc.org/abstract/MED/24795141

PubMed publication ID

24795141

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24795141

retrieved

11 April 2018

reference URL

http://europepmc.org/abstract/MED/24795141

(Q51748897)

The dose-dependent tumor targeting of antibody-IFNγ fusion proteins reveals an unexpected receptor-trapping mechanism in vivo.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)